Small Research Grant Program for the Next Generation of Researchers in Alzheimer's Disease (R03)
Offered by American Federation for Aging · New York, NY
About this opportunity
Supports early-stage investigators and established researchers new to Alzheimer's disease research with $200,000 over 2 years. Approximately 12 awards given annually.
How to apply
Applications are handled on the funder's own website. Review the full guidelines and apply here: afar.org/funding-opportunities. Confirm the deadline and eligibility directly with American Federation for Aging before applying.
See American Federation for Aging's full giving profile — its grant history, top recipients, and other funding priorities.
Is this grant a fit for your nonprofit?
Before you spend hours on an application, know whether it's worth it. Bespoke Grants scores any open RFP against your mission, budget, and service area — and finds the other funders you're missing. Free, no credit card.
Check my fit & find more grants →Other open opportunities from American Federation for Aging
American Federation for Aging currently lists 6 open opportunities in our index.
- The Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76)
- The Sagol Network GerOmic Award for Junior Faculty
- AFAR Grants for Junior Faculty and Glenn Foundation for Medical Research (GFMR) Grants for Junior Faculty
- Glenn Foundation for Medical Research (GFMR) Discovery Award
- Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research
Frequently asked questions
- What is the deadline for Small Research Grant Program for the Next Generation of Researchers in Alzheimer's Disease (R03)?
- The application deadline is Rolling (no fixed deadline). Deadlines can change — always confirm directly with American Federation for Aging before applying.
- How much funding is available?
- The award range is $200K – $200K.
- Where do I apply?
- Applications are submitted through American Federation for Aging's own website or process — see the "How to apply" section above.